1. Home
  2. ALLR vs HXHX Comparison

ALLR vs HXHX Comparison

Compare ALLR & HXHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • HXHX
  • Stock Information
  • Founded
  • ALLR 2004
  • HXHX 2003
  • Country
  • ALLR United States
  • HXHX China
  • Employees
  • ALLR N/A
  • HXHX N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • HXHX Trucking Freight/Courier Services
  • Sector
  • ALLR Health Care
  • HXHX Industrials
  • Exchange
  • ALLR Nasdaq
  • HXHX Nasdaq
  • Market Cap
  • ALLR 15.8M
  • HXHX 19.0M
  • IPO Year
  • ALLR N/A
  • HXHX 2025
  • Fundamental
  • Price
  • ALLR $0.94
  • HXHX $1.00
  • Analyst Decision
  • ALLR Strong Buy
  • HXHX
  • Analyst Count
  • ALLR 1
  • HXHX 0
  • Target Price
  • ALLR $9.00
  • HXHX N/A
  • AVG Volume (30 Days)
  • ALLR 367.8K
  • HXHX 134.7K
  • Earning Date
  • ALLR 08-15-2025
  • HXHX 01-01-0001
  • Dividend Yield
  • ALLR N/A
  • HXHX N/A
  • EPS Growth
  • ALLR N/A
  • HXHX N/A
  • EPS
  • ALLR N/A
  • HXHX 0.26
  • Revenue
  • ALLR N/A
  • HXHX $25,571,810.00
  • Revenue This Year
  • ALLR N/A
  • HXHX N/A
  • Revenue Next Year
  • ALLR N/A
  • HXHX N/A
  • P/E Ratio
  • ALLR N/A
  • HXHX $3.39
  • Revenue Growth
  • ALLR N/A
  • HXHX N/A
  • 52 Week Low
  • ALLR $0.61
  • HXHX $0.84
  • 52 Week High
  • ALLR $6.00
  • HXHX $6.29
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 47.03
  • HXHX N/A
  • Support Level
  • ALLR $0.85
  • HXHX N/A
  • Resistance Level
  • ALLR $1.01
  • HXHX N/A
  • Average True Range (ATR)
  • ALLR 0.05
  • HXHX 0.00
  • MACD
  • ALLR -0.01
  • HXHX 0.00
  • Stochastic Oscillator
  • ALLR 47.55
  • HXHX 0.00

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

Share on Social Networks: